Comerica Bank
LCTX icon

Comerica Bank’s Lineage Cell Therapeutics LCTX Stock Holding History

Comerica Bank’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$7.68M Hold
4,600,000
– – 0.03% 426
2025
Q3 		$7.77M Hold
4,600,000
– – 0.03% 499
2025
Q2 		$4.17M Buy
4,600,000
+1,600,000
+53% +$949K 0.02% 758
2025
Q1 		$1.35M Buy
3,000,000
+2,200,000
+275% +$1.29M 0.01% 1328
2024
Q4 		$402K Buy
800,000
+550,000
+220% +$404K ﹤0.01% 1984
2024
Q3 		$226K Hold
250,000
– – ﹤0.01% 2246
2024
Q2 		$249K Sell
250,000
-295
-0.1% -$326 ﹤0.01% 2167
2024
Q1 		$370K Buy
250,295
+250,000
+84,746% +$283K ﹤0.01% 2029
2023
Q4 		$322 Hold
295
– – ﹤0.01% 3686
2023
Q3 		$348 Buy
+295
New +$401 ﹤0.01% 3738

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return